You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Funded Evidence-Informed Regimens

Drug and regimen monographs and information sheets for patients provide information on dosing and administering cancer treatment protocols. They are for general reference and are not meant to replace prescribing information or physician recommendations.

If you have questions about ST-QBP funding on our website, please visit our Frequently Asked Questions page.

Find enhanced Regimen Patient Information Sheets, created in collaboration with patient and family advisors.

Regimens

14 Items
Cancer Type: Gastrointestinal, Esophagus, Gastric / Stomach     
Intent: Palliative
Aug 2017
Cancer Type: Gastrointestinal, Pancreas     
Intent: Palliative
Funding:
New Drug Funding Program
    Oxaliplatin and Irinotecan - Advanced Pancreatic Cancer (FOLFIRINOX)
May 2017
Cancer Type: Gastrointestinal, Hepatobiliary / Liver / Bile Duct, Pancreas     
Intent: Palliative
Sep 2017
Cancer Type: Gastrointestinal, Colorectal     
Intent: Adjuvant
Feb 2017
Cancer Type: Gastrointestinal, Pancreas     
Intent: Adjuvant, Palliative
Feb 2017
Cancer Type: Gastrointestinal, Hepatobiliary / Liver / Bile Duct     
Intent: Palliative
Sep 2017
Cancer Type: Gastrointestinal, Esophagus, Gastric / Stomach     
Intent: Adjuvant, Adjuvant
Nov 2017
Cancer Type: Gynecologic, Gestational Trophoblastic Disease     
Intent: Curative
Oct 2017
Cancer Type: Head and Neck     
Intent: Palliative
Feb 2017
Cancer Type: Gynecologic, Gestational Trophoblastic Disease     
Intent: Curative
Nov 2017
Cancer Type: Hematologic, Lymphoma - Non-Hodgkin's Low Grade, Multiple Myeloma     
Intent: Palliative
Dec 2017
Cancer Type: Gynecologic, Ovary     
Intent: Palliative
Funding:
New Drug Funding Program
    Topotecan - Single Agent Treatment of Platinum Sensitive Ovarian Fallopian Tube or Primary Peritoneal Cancer
New Drug Funding Program
    Topotecan - Platinum-Resistant Ovarian Fallopian Tube or Primary Peritoneal Cancer
Aug 2017